
Tempsens Instruments IPO Sees Massive 105% GMP as Subscription Crosses 21x Mark
The Tempsens Instruments IPO is generating significant pre-listing hype after the stock commands a remarkable Grey Market Premium (GMP) of 105%. The issue, which commenced public bidding on Thursday, August 20, 2026, has seen strong demand leading to its subscription reaching 21.66 times by the end of Day 2.The company is raising a total of Rs 650 crore through the offering. This includes a fresh issue comprising 32 lakh shares worth Rs 95 crore and an Offer for Sale (OFS) valued at Rs 555 crore, involving 1.85 crore shares. The IPO is priced between Rs 285 to Rs 300 per share, with one lot containing 50 shares.
Subscription Status Reveals Robust Investor Appetite
The IPO has garnered diverse strong support across all investor categories. Overall, the issue stands subscribed 21.66 times against a total of 1.51 crore shares on offer.Retail Individual Investors (RIIs) showed exceptional conviction, with their segment being sought after 18.67 times against 75.65 lakh shares reserved. Meanwhile, Non-Institutional Investors (NIIs) responded even more aggressively, subscribing the portion 52.98 times against 32.42 lakh shares.
Qualified Institutional Buyers (QIBs) also participated robustly, with their allocation subscribed at 3.31 times against 43.23 lakh shares available for subscription. Anchor investors contributed Rs 194.54 crore prior to the public opening, having been allotted 64,84,999 equity shares at Rs 300 per share.
IPO Grey Market Premium and Listing Expectations
The latest GMP stands at Rs 313, representing a substantial 105% premium over the upper price band of Rs 300 per share. Based purely on this unofficial market indicator, the estimated listing price could reach around Rs 613 per share, indicating potential for considerable listing gains.It is important to note that GMP remains an unverified, non-guaranteed market sentiment indicator and its fluctuations are possible before trading commences. The IPO is scheduled to close on August 24, 2026, with the proposed listing date set for August 28, 2026.
Financial Health and Future Use of Proceeds
Tempsens Instruments demonstrated solid financial momentum in FY26. The company’s total income rose by 19% year-on-year to Rs 455.86 crore from Rs 382.47 crore in FY25. Profit After Tax (PAT) also improved, increasing 14% to Rs 71.07 crore compared to Rs 62.56 crore in the previous financial year.The funds raised are earmarked for strategic growth and debt management. Of the net proceeds from the fresh issue, Rs 18.13 crore will be allocated towards capital expenditure within its electrical heating and specialised cable solutions businesses. A significant portion of Rs 55 crore is dedicated to prepayment or scheduled repayment of outstanding borrowings.
Expert Viewpoint on Valuation and Investment Outlook
AnandRathi’s research notes that based on FY26 earnings at the upper end of the IPO price band, Tempsens Instruments holds an implied P/E multiple of 35.4x and an EV/EBITDA multiple of 25.64x. The brokerage suggests that while the company’s expanding international footprint and diversified product portfolio support a premium valuation, the IPO appears fully valued at the upper price band.Despite the premium assessment, Anand Rathi has maintained a “Subscribe: Long Term” rating for the issue, advising investors with a long-term investment horizon to consider subscribing.
Company Profile and Global Reach
Established in 1990, Tempsens Instruments is a key manufacturer of thermal engineering products and specialised cables. The company specializes in designing and manufacturing customised temperature-sensing solutions and electrical heating systems.The firm holds a notable market position, being one of the top manufacturers of both contact and non-contact temperature sensors in India by revenue. Furthermore, its operational footprint is global; Tempsens Instruments exports products to over 80 countries, including Germany and Poland. Their markets span across Europe, Africa, the Middle East, Asia Pacific, North America, and South America.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.